Correlation Between Fidus Investment and Spyre Therapeutics
Can any of the company-specific risk be diversified away by investing in both Fidus Investment and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fidus Investment and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fidus Investment Corp and Spyre Therapeutics, you can compare the effects of market volatilities on Fidus Investment and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fidus Investment with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fidus Investment and Spyre Therapeutics.
Diversification Opportunities for Fidus Investment and Spyre Therapeutics
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Fidus and Spyre is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Fidus Investment Corp and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Fidus Investment is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fidus Investment Corp are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Fidus Investment i.e., Fidus Investment and Spyre Therapeutics go up and down completely randomly.
Pair Corralation between Fidus Investment and Spyre Therapeutics
Given the investment horizon of 90 days Fidus Investment Corp is expected to generate 0.18 times more return on investment than Spyre Therapeutics. However, Fidus Investment Corp is 5.62 times less risky than Spyre Therapeutics. It trades about 0.18 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about -0.05 per unit of risk. If you would invest 1,976 in Fidus Investment Corp on September 15, 2024 and sell it today you would earn a total of 162.00 from holding Fidus Investment Corp or generate 8.2% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Fidus Investment Corp vs. Spyre Therapeutics
Performance |
Timeline |
Fidus Investment Corp |
Spyre Therapeutics |
Fidus Investment and Spyre Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Fidus Investment and Spyre Therapeutics
The main advantage of trading using opposite Fidus Investment and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fidus Investment position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.Fidus Investment vs. Visa Class A | Fidus Investment vs. Diamond Hill Investment | Fidus Investment vs. Distoken Acquisition | Fidus Investment vs. AllianceBernstein Holding LP |
Spyre Therapeutics vs. Puma Biotechnology | Spyre Therapeutics vs. Iovance Biotherapeutics | Spyre Therapeutics vs. Day One Biopharmaceuticals | Spyre Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Stocks Directory Find actively traded stocks across global markets | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |